Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT05188664 · COMPLETED
Trial details
- NCT number
- NCT05188664
- Sponsor
- LaNova Australia Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2023-11-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.